MUC1 and colorectal carcinoma: These findings suggest that Mucin-1 expression is a promising prognostic factor for CRC and may serve as a valuable biomarker for identifying the metastatic potential of the disease, but it may also be a promising target for future immunotherapy with the idea of reducing the risk of metastasis and increasing survival in patients with CRC [49,50].